Candid On Cancer: Interview with Penn Medicine's Dr. Robert Vonderheide - Bench to Bedside

Penn Medicine's Abramson Cancer Center incorporates a bench to bedside approach to treating cancer that keeps providers at the patient's bedside connected to the researchers in the lab developing the therapies. In this video Dr. Robert Vonderheide, Director of the Abramson Cancer Center explains what bench to bedside means and how it impacts the patients treated at Penn.

Twitter @PennMDForum 


March 1, 2023

Created by

Penn Physician VideoLink

Related Presenters

Robert Vonderheide, MD, DPhil

Robert Vonderheide, MD, DPhil

Medical Oncology

Director of the Abramson Cancer Center
John H. Glick Abramson Cancer Center Professor

View full profile